Article
[Genetic testing for cystic fibrosis: evaluation of the Elucigene CF20 kit in blood and buccal cells].
Annales de biologie clinique - 1 Jan 2000
Feldmann D, Guittard C, Georges M D, Houdayer C, Magnier C, Claustres M, Couderc R
Abstract excerpt
Routine determination of mutations in cystic fibrosis requires accurate, rapid, reliable and low-cost methods, permitting the simultaneous detection of multiple mutations. The Elucigene CF20 kit developped by Cellmark Diagnostics, uses multiplex ARMS, which allows the screening for 20 CFTR gene mutations (deltaF508, G542X, N1303K, 1717-1G>A, G551D, W1282X, R553X, deltaI507, 1078delT, 2183AA>G, 3849+10kbC>T,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
